Back to search
Non-Germline BRCA Mutated Ovarian Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Germline BRCA Mutated Ovarian Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Germline BRCA Mutated Ovarian Cancer trials you may qualify forThis phase II trial studies how well talazoparib works in treating patients with cancers that have returned after a period of improvement, do not respond to tre…
The purpose of the study is to assess the efficacy and safety of single-agent olaparib as a maintenance treatment in patients with relapsed High Grade Serous Ov…
This is an open label, single arm, multi-center study to assess the efficacy and safety of the combination of cediranib and olaparib tablets in platinum-resista…